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Summary 
A monoclonal antibody, RE2,  raised by immunizing a rat with cell lysate of a mouse T  cell 
done, was found to directly kill interleukin 2-dependent T  cell clones without participation 
of serum complement. Fab fragments of RE2 had no cytolytic activity, while the cross-linking 
of Fab fragments with anti-rat immunoglobulin reconstituted the cytotoxicity. The cytotoxicity 
was temperature dependent: the antibody could kill target cells at 37~  but not at 0~  Sodium 
azide, ethylenediaminetetraacetic acid, and forskolin did not affect the cytolytic activity of RE2, 
while the treatment of target cells with cytochalasin B and D  completely blocked the activity. 
This suggested that the cell death involves a cytoskeleton-dependent active process.  Giant holes 
on the cell membrane were formed within 5 minutes after the treatment with RE2, as observed 
by scanning electron microscopy. There was no indication of DNA fragmentation nor swelling 
of mitochondria during the cytolysis, suggesting that the cell death is neither apoptosis nor typical 
necrosis.  The antibody also killed T  cell lymphomas and T  and B cell hybridomas only when 
these cells were preactivated with concanavalin A, lipopolysaccharide,  or phorbol myristate acetate. 
Preactivated peripheral T  and B cells were sensitive to the cytotoxicity of RE2,  while resting 
T and B cells were insensitive.  These results provide evidence for a novel pathway of cell death 
of activated lymphocytes by membrane excitation. 
A 
tive cell death is an important mechanism in deleting 
useless  or harmful cells from organisms to maintain 
normal ontogenic and homeostatic pathways (1-3). It is par- 
ticularly important in the immune system, where lymphoid 
cells with autoreactive and useless receptors should be ex- 
cluded in central and peripheral lymphoid organs (4, 5). The 
best-known  mechanisms  of cell  death  are  apoptosis  and 
necrosis. The negative selection of developing T cells is known 
to be the result of apoptotic death of thymocytes having au- 
toreactive TCRs (6). The cytolysis caused by cytotoxic T and 
NK cells is apoptotic death, where an active process resulting 
in DNA fragmentation is involved (7).  Cytokines such as 
TNF and lymphotoxin are known to induce apoptosis of target 
cells (8).  On the other hand, immune mechanisms can in- 
duce necrotic death of somatic cells with antibody and com- 
plement. Autoantibodies can cause necrotic cell death with 
the aid of complement and macrophages. Necrosis caused by 
complement attack, for example, is characterized by swelling 
of cells, rupture of plasma membranes, and swelling of mito- 
chondria (5). Both mechanisms are effectively  used in the im- 
mune system to maintain and protect the organism. 
2007 
We found that a particular mAb raised against cell surface 
components of a T cell clone constantly killed activated lym- 
phoid cells of T  and B cell lineage without complement- 
dependent membrane damage. The resting T and B cells, as 
well as nonlymphoid somatic cells, were not killed by the 
antibody. The cell death was distinct from apoptosis and the 
usual pattern of necrosis.  It involved an active process initi- 
ated by the cross-linking of cell surface components. Since 
only the activated T and B cells were killed by the antibody, 
it was speculated that this process may play a role in avoiding 
autoreactivity of lymphoid cells under certain circumstances. 
This report describes properties of this mAb and character- 
istic features of cell death caused by the antibody. 
Materials and Methods 
Animals 
C3H/HeN (C3H) mice were purchased from Japan SCL Inc. 
(Hamamatsu, Japan). Sprague-Dawley  rats and a hamster were pur- 
chased from Charles River Japan Inc. (Atsugi, Japan). 
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Splenic Cells.  A T  cell-enriched population was obtained as 
spleen ceils nonadherent to anti-mouse Ig-coated dishes as described 
previously (9). To obtain splenic B cells, spleen cells were depleted 
of T cells by treatment with T call-specific rabbit anti-mouse brain 
serum and complement as described previously (10). 
T Cell Clones.  IL-2-dependent T  cell clones with helper and 
suppressor functions have been established from C3H, C57BL/6, 
and (B6  x  C3H)Ft mice as previously described (11-13). 
B Cell Lines.  Immature B cell clones  46.6  and Ig 6.3  and B 
cell line WEHI 231 of (BALB/c  x  NZB)F1 mice were gifts of Dr. 
T.  Takemori (National Institute of Health,  Tokyo, Japan) (14). 
Lymphoid Tumor Cell Lines.  EL-4, K/VIA (15), and RMA-S (a 
class I-defective mutant line derived from KMA) (16) were used 
as T  cell leukemic cell lines. 
T and B Celt Hybridomas.  T  cell hybridoma 7C3-13  has been 
described previously (17). B cell hybridoma LK35.2 was a gift from 
Dr. A. Singer (National Institutes of Health, Bethesda, MD) (18). 
B cell hybridoma TA3 was a gift from Dr. N. Shinohara (Mitsubishi- 
Kasei Institute of Life Science,  Tokyo, Japan) (19). 
Nonlymphoid Tumor Cells.  The B16 melanoma cell line was a 
gift from Dr. M. Taniguchi (Center for Neurobiology and Molec- 
ular  Immunology,  Chiba  University,  Chiba,  Japan)  (20).  The 
MH134 hepatoma cell line was a gift from Dr. H. Fujiwara (Osaka 
University, Osaka, Japan) (21). 
Transfectant.  A murine Fas antigen transfected (22,  23) Jurkat 
cell line, J6 (24),  was kindly provided by Dr.  S.  Nagata (Osaka 
City Institute of Public Health and Environmental Sciences, Osaka, 
Japan) (22). 
Culture Medium 
The medium used for maintaining the cell lines was KPMI-1640 
medium (Gibco Laboratories, Grand Island, NY) supplemented with 
2 mM L-glutamine, 50/~M 2-ME, and 10% heat-inactivated FCS. 
The culture medium for IL-2-dependent T  cell clones was addi- 
tionally supplemented with 5% Con A-stimulated culture super- 
natant of rat spleen  cells as an IL-2 source. 
Antibodies 
Anti-K  k mAb (11-4.1) (25),  anti-D k mAb (15-5-5s)  (26),  anti- 
K b mAb (28-8-6s) (27), anti-fl2-microglobulin (allotype b specific) 
($19.8) (28}, and anti-CD3 mAb (145-2Cll) (29) were purified by 
protein A-Sepharose (Pharmacia LKB, Biotechnology AB,  Upp- 
sala, Sweden)  or by precipitation with 40% saturation of ammo- 
nium sulfate  at pH 7.2. 
Production of RE2 mA b 
A rat was immunized intraperitoneally four times with NP-40 
lysates of a MS-S2 (12) T  cell clone absorbed with anti-I-Jk-cou  - 
pled (30-32) Sepharose 4B. 3 d after the last immunization,  rat 
spleen cells were fused with P3U1  nonproducing myeloma cells 
by the polyethyleneglycol method, and hybridomas were selected 
by culturing in the presence of a mixture of 100 #M of hypoxan- 
tine, 4 #M of aminopterin, and 16 #M of thymidine. To increase 
the efficiency of hybridization, 400 U/ml of recombinant IL-6 was 
added in the selection  medium as previously described (33).  Hy- 
bridomas producing  antibodies  that  reacted  with  MS-S2  were 
selected by microfluorimetry. Five hybridomas, RE1 to RES, were 
selected and cloned by limiting dilution. All of the mAbs produced 
by these hybridomas were IgG class and widely cross-reactive with 
the molecules of MHC chss I family (Kishimoto, H., K. Sano, 
S. Matsuoka, Y. Asano, and T. Tada, manuscript in preparation). 
Production of $27 mAb 
A hamster was immunized with immunoprecipitates from ly- 
sate of the MS-S2 T cell clone by RE2 mAb. The spleen cells of 
the hamster were fused with P3U1 cells as described above. Hy- 
bridomas were selected by cytolytic activity on the MS-S2 T  cell 
clone, 
Papain Digestion of RE2 mAb 
KE2 mAb was digested by papain to yield Fab fragments by 
the method of Kousseaux et al. (34).  Briefly, purified RE2 mAb 
at a concentration of 1.4 mg/ml was digested with mercuripapain 
(Sigma Chemical Co., St.  Louis,  MO) in the presence of 1 mM 
cysteine at the enzyme/protein ratio of 1% (wt/wt) for 18 h at 37~ 
Reagents 
The following reagents were used. Forskolin (20 #g/ml; Sigma 
Chemical Co.) was added to the target cell for 1 h before cytolytic 
assay where  stated.  Sodium  azide  (50  mM),  EDTA  (30  raM), 
cytochalasin B (10/~g/ml;  Sigma Chemical Co.), or cytochalasin 
D (15/zg/ml; Sigma Chemical Co.) were added to the assay medium 
during  the cytolytic assay to test the effect of these reagents. 
Assay of Cytolytic Activity 
Target cells were resuspended  at  10V/ml in  RPMI  1640  sup- 
plemented with 2% FCS. mAb was added at 3 #g/ml to the cell 
suspension after decomplementation. Cells were incubated at 37~ 
for 1 h unless  otherwise stated. The percentage of cell lysis was 
determined by dye exclusion using trypan blue in duplicate or tripli- 
cate and was calculated  by the following formula: 
Percent of cytotoxicity  A  -  B  x  100, 
A 
where A is the number of live cells after incubation without mAh 
and B is the number of live cells after incubation with mAb. The 
percentage of cell lysis of T  cells adherent to culture dishes  was 
determined by calculating the live cell number after incubating the 
dishes  with  mAbs. 
Electron Microscopic Study 
Scanning Electron Microscopy.  To prepare the cells for observa- 
tion with a scanning electron microscope, MS-S2 cells were in- 
cubated with RE2 at 37~  for 0, 5, and 20 min and then washed 
with and resuspended in PBS containing 2% FCS. The suspension 
was fixed with 10 vol of 1% glutaraldehyde in 0.1 M cacodylate 
buffer (pH 7.3) at 4~  for 2 h. The fixed cells were washed with 
0.1  M  cacodylate buffer, postfixed for 1 h  in  1%  OsO4 at 4~ 
and dehydrated in 50--100%  ethyl alcohol followed by drying in 
tertiary butyl alcohol with a freeze-drying instrument (ID-2; Giko, 
Tokyo,  Japan).  The cells  were  mounted  on  electric  conductive 
double-sided  tape  (Nisshin-EM,  Tokyo,  Japan)  coated  with  a 
gold-palladium coating system (Polaron, England), and they were 
examined by a scanning electron microscope (model S-430; Hitachi 
Ltd.,  Tokyo, Japan). 
Transmission Electron  Microscot~.  MS-S2 cells were incubated with 
RE2 or RE1 at 37~  for 20 min and fixed by 2.5% glutaraldehyde 
and 2% paraformaldehyde in 0.1  M  cacodylate buffer (pH 7.3). 
The cells were postfixed by 1% OsO4 in 0.1 M cacodylate buffer 
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hydrated  in a graded series of  ethyl alcohol  and embedded in Spurr's 
resin (low viscosity embedding media; Polysciences Inc., War- 
rington, PA). Silver to gold sections were cut and examined with 
a transmission  electron microscope  (modelJEM-1200Ex;  JEOL Ltd., 
Tokyo, Japan). 
Analysis of DNA Fragmentation by Agarose Gel Electrophoresis 
Aliquots of 2  x  106 MS-S2 cells were incubated with RE 
mAbs for 30 min at 37~  and 6  x  106 thymocytes were in- 
cubated with 1.2 #M of dexamethasone for 8 h at 37~  After 
incubation, the cells were resuspended  in TNE buffer (10 mM Tris, 
100 mM NaC1, 1 mM EDTA, pH 7.5) containing 0.5% SDS and 
further incubated for 7 h at 37~  in the presence of 100/~g/ml 
ofproteinase K (Sigma Chemical Co.). Samples  of  DNA were pre- 
pared by phenolchloroform  extraction and ethanol precipitation fol- 
lowed by RNase treatment.  6/~g of DNA was electrophoresed 
in a 2% agarose gel prepared in TAE buffer (40 mM Tris-acetate, 
2 mM EDTA, pH 7.5) containing 0.3 #g/ml ethidium bromide 
and visualized by UV light. 
Cell Staining and Flow Cytometry 
Suspension of normal thymocytes, spleen  cells, and a T cell lym- 
phoma RMA and its MHC class I-defective mutant line RMA-S 
were stained with RE2 mAb followed by incubation with FITC- 
conjugated mouse anti-rat Ig. To study the inhibition of binding 
of anti-class I mAbs, MS-S2 cells were first incubated with RE2 
mAb and further incubated with FITC-conjugated  anti-K  k (11-4.1) 
or anti-D k (15-5-5s) mAbs. Fluorescence analysis of stained cells 
was performed  with a flow cytometer  (FACStar  plus  |  Becton Dick- 
inson & Co., Mountain View, CA) (33). 
Surface Labeling of Cells, Immunoprecipitation, and 
Gel Electrophoresis 
Cell surface iodination of spleen cells, MS-S2 cells, and 24-2 cells 
was performed by chemical reaction catalyzed by Iodogen (Pierce 
Chemical Co., Rockford, IL) as described previously (35). After 
radiolabeling, the cells were lysed with 1% NP-40. Aliquots of 
lysates were mixed and precipitated with mAbs coupled to protein 
A- or protein G-Sepharose as described (32). The immunoprecipi- 
tares were dissolved  in SDS sample  buffer (2.3% SDS, 10% glycerol, 
62.5 mM Tris, pH 6.8) and analyzed by SDS-PAGE as described 
by Laemmli (36). 
Results 
Cytotoxic Activity of RE2 for T Cell Clones.  In the course 
of screening the mAb produced against the immunoprecipi- 
tate of anti-I-J and the lysate of T cell clone MS-S2, we in- 
cidentally found that one mAb (RE2) constantly killed mouse 
IL-2-dependent T cell clones when cells were incubated with 
the mAb at 4~  for staining and flow cytometric analysis. 
Fig.  1 shows the result of an experiment where a CD4 + 
Th2 T  cell clone MS-S2 was incubated with RE2 mAb at 
37~  for various incubation periods.  The treatment induced 
rapid cell lysis at 37~  60% of cells were killed even within 
15 min, and >90%  were killed at 60 min. About 60% of 
cells were also killed at 60 min, if they were incubated at 
4~  The cytotoxicity was independent of serum comple- 
ment since the heating of ascitic fluid at 56~  for 30 min 
did not affect the cytotoxicity. The killing of cells occurred 
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Figure  1.  Kinetics  ofcytotoxic  effect  of RE2 mAb on T cell  clone  MS- 
$2. MS-S2 cells were incubated with RE2 and RE1 mAbs as described 
in Materials  and Methods. Cytotoxic  activity  of RE2 at 37~  (e), 4~ 
(Q), 0~  (O), and of RE1 at 37~  (A) were measured at the indicated 
times. MS-S2  cells  were also treated  with Fab fragments  of RE2 (D). The 
one group of Fab fragment-treated  cells was further  treated  with anti-rat 
lg (R). They were incubated at 37~  for 1 h. 
even under serum-free culture conditions. However, no cyto- 
toxicity was observed  when the reaction mixture was kept 
at 0~  suggesting the presence of an active process in the 
target  cells.  An  Ig  class-matched control  rat  mAb  RE1 
(IgG1) produced by the same hybridization procedure did 
not show cytotoxicity  under the same conditions. RE1 mAb 
was  shown to react  with similar  molecular species on the 
surface of target cells in the immunoprecipitation (see below). 
Cytotoxicity of RE2 on Various Cell Populations.  The cyto- 
lytic activity of RE2 was tested on various IL-2-dependent 
T  cell lines,  lymphomas, and hybridomas of T  and B cell 
origins (Table 1 A). All IL-2-dependent T cell clones in the 
suspension  were killed at variable degrees.  When the mAb 
was added to the same cells attached to plastic culture dishes, 
however, RE2 was unable to kill the cells (see asterisk in Table 
1 A). This peculiar property will be discussed below. Three 
lymphomas and hybridomas from stationary culture were not 
killed by RE2. However, they became sensitive to the cyto- 
toxicity of RE2 after activation by mitogens such as Con 
A or LPS. Three transformed B lineage cell lines and several 
nonlymphoid tumor cell lines tested were insensitive to the 
treatment with RE2 even after incubation with appropriate 
mitogenic stimuli. Therefore, the cytolytic effect of RE2 mAb 
appears to have a preferential effect on activated lymphoid cells. 
We also tested the cytolytic activity of RE2 on spleen cells, 
bone marrow cells, lymph node cells, and thymocytes of C3H 
mice. Splenic T and B cells and lymph node cells were killed 
by the antibody only after activation with the appropriate 
mitogens (Table 1 B). The same results were obtained with 
the spleen  cells of other mouse strains of H-2  b and H-2  d 
(data not shown). Thymocytes were not killed by RE2 mAb 
before and after activation with various reagents. Bone marrow 
cells were not killed. Although RE2 mAb was able to stain 
all lymphoid cells including .thymocytes, spleen cells, bone 
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Target ceils  Origin 
Percent of 
cytotoxicity with 
Cell type  Rs  RE1 
28-4  B6C3F1 
MS-S2  C3H 
MS-S2  (adherent)* 
24-2  B6C3F1 
9-5  B6C3F1 
HD8  C3H 
EL4 (not treated)  B6 
(Con A  treated) 
7C3-13  (not treated)  B10.BR 
(rat Con A  sup  treated) 
TA3 (not treated)  CAF1 
(LPS treated) 
LK35.2 (not treated)  B10.BR 
(LPS treated) 
46.6  BALB/c 
Ig6.3  BALB/c 
WEHI231  BALB/c 
B16  (not treated)  B6 
(IFN-  7  treated) 
MH134  (not treated)  C3H 
(IL-6 treated) 
CD4+Thl  65.3  <1.0 
CD4+Th2  90.0  <1.0 
<1.0  <1.0 
CD4 §  45.3  <1.0 
CD4 §  Ts  90.0  <1.0 
CD8 +  Ts  41.4  4,4 
T  cell lymphoma  <1.0  <1,0 
60.0  <1.0 
T  cell hybridoma  <1.0  <1.0 
92.1  <1.0 
B cell lymphoma  <1.0  <1.0 
45.4  <1.0 
B cell hybridoma  <1.0  <1.0 
<1.0  <1.0 
Pro-B  <1.0  <1.0 
Pre-B  <1.0  <1.0 
B  <1.0  <1.0 
Melanoma  <1.0  <1.0 
<1.0  <1.0 
Hepatoma  <1.0  <1.0 
<1.0  <1.0 
Table  1 B.  Cytotoxicity of RE2 on Normal Cells 
Percent of 
cytotoxicity with 
Target cells  RE2  RE1 
Thymocytes  <1.0  <1.0 
Con A-activated thymocytes  <1.0  <1.0 
Anti-CD3-activated  thymocytes  <1.0  <1.0 
Spleen  cells  <1.0  <1.0 
Con A-activated spleen  cells  40.0  <1.0 
Con  A-activated splenic  T  cells  78.9  <1.0 
LPS-activated splenic  B cells  54.5  <1.0 
Normal lymph node cells  <1.0  <1.0 
Con A-activated lymph node cells  41.0  <1.0 
In both parts of this table, cells were incubated with RE mAbs for 1 h 
at 37~  The percentage of cytotoxicity was evaluated as described in 
Fig. 1. Some tumor cell lines and hybridomas were treated with the in- 
dicated reagents or 5% Con A-stimulated culture supernatant of rat spleen 
cells for 12-24 h before cytolytic assay. Thymocytes and spleen cells of 
C3H  mice were incubated with or without Con  A (2 /xg/ml), LPS 
(5/~g/ml),  and anti-CD3 mAb (3 /~g/ml) for 24-48 h at 37~ 
marrow cells,  and lymph node cells, the mAb was  able to 
kill the peripheral lymphoid cells only when they were ac- 
tivated. 
Electron Microscopic Findings.  The  morphology  of cells 
treated with RE2 mAb was studied by scanning electron mi- 
croscopy. Giant pore formation was observed on the surface 
of target T  cells in an early phase (5-20 min) of killing by 
RE2  (Fig.  2).  As early as 5 rain after the incubation with 
the antibody, giant holes were formed on the surface of target 
ceils. The diameter of the holes reached ~2/~m. The number 
of holes observed was variable, but one to six holes were gener- 
ally observed on the ceils. In the transmission  electron mi- 
croscopic analysis, destruction of plasma membrane, dilation 
of the endoplasmic reticulum, and deformation and conden- 
sation of mitochondrias were observed, while chromatins of 
their nuclei were almost intact (Fig. 3). These findings are 
distinct from those observed in apoptotic or typical necrotic 
cell death. To further discriminate the RE2-induced cell death 
from apoptosis, we analyzed the DNA of the antibody-treated 
ceils (Fig. 4). The DNA extracted from the RE2-treated MS-S2 
cells showed no degraded DNA, ~uggesting this type of cell 
death is different from that  of apoptosis. 
Requirement of Cross-Linking of Cell Su~ace Molecules  for Cyto- 
toxic Activity of RE2.  To determine whether  the binding 
of RE2  mAb  to cell surface molecules is  sufficient for in- 
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taken as described in Materials and Methods. Bars, 1 #m. 
ducing  cell lysis,  the T  cell clone  MS-S2 cells were treated 
with intact RE2 mAb or its Fab fragments at 37~  for 1 h. 
The treatment of cells with intact RE2 mAb always induced 
cell lysis, while Fab fragments of RE2 failed to do so. How- 
ever,  cross-linking  of  the  cell-bound  Fab  fragments  with 
anti-rat Ig reconstituted  the cytolysis (Fig.  1).  These results 
indicate  that  a cross-linking of target molecules is required 
for  triggering  of  the  antibody-mediated,  complement- 
independent  cytolysis. 
Blocking of Cytotoxicity by Cytochalasin.  To learn the mech- 
anism of cell death induced by RE2,  various reagents were 
added to the reaction mixture as described in Materials and 
Figure  3.  Transmission electron microscopic findings. MS-S2 cells were incubated with RE1 (A) or RE2 (B) for 20 min at 37~  Electron micro- 
graphs were taken as described  in Materials and Methods. Arrowheads indicate disruption of plasma membrane, rer,  rough-surface endoplasmic  reticulum. 
Bars, 1 /zm. 
2011  Matsuoka et al. Hgmee 4.  No findings of DNA frag- 
mentation.  MS-S2 cells were incubated 
without mAb (lane I) or with RE1 mAb 
(lane 2) and RE2 mAb (lane 3) for 30 min 
at 37°C. Thymocytes  of a C3H mouse 
were incubated with dexamethasone for 
8 h  (lane 4).  Total DNA was prepared 
from the treated cells and dectrophoresed 
as described in Materials and Methods. 
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Methods. As shown in Fig. 5, forskolin, EDTA, and sodium 
azide failed to interfere with the RE2-induced cell death, sug- 
gesting  that  neither  the  elevation  of cytoplasmic  cAMP, 
Ca  2+ influx,  nor capping was involved in the cell death.  In 
contrast,  the  addition  of cytochalasin B  or cytochalasin D 
completely blocked the cytolysis. As shown in Fig. 6, when 
cytochalasin D  was added before the incubation with RE2, 
the cytolytic activity of RE2 was completely abrogated. When 
cytochalasin D  was added at various times after incubation 
with  the  antibody,  the  cell lysis  was stopped at  that  time 
point,  and  no  further  cell death  was observed. 
Expression of  the RE2 Determinant on Thymocytes and Spleen 
Cells•  Fig. 7 a shows the expression of the RE2 determinant 
on thymocytes and spleen cells derived from a C3H mouse. 
The RE2 determinant was expressed on thymocytes and spleen 
cells of mouse strains  with different H-2 haplotypes. It was 
also detectable on the cell membrane of virtually all the tissues 
including the liver and thymic supportive tissues, suggesting 
that the RE2 epitope is ubiquitously expressed on all somatic 
cells (data not shown). However, tissue cells and tumor cells 
were insensitive to the cytolytic effect of RE2. Since ubiqui- 
tous expression of RE2 on lymphoid cells suggested that the 
determinant  could be a class I molecule,  a relationship  be- 
tween RE2 and class I molecules was deduced by a competi- 
tive inhibition study of staining.  As shown in Fig. 7 b, RE2 
was able to partially inhibit the staining of H-2  k T  cell clone 
Figure  6.  Effect of cytochalasin D on cytotoxicity of RE2 at various 
times during the assay. 20/*g/ml of cytochalasin D was added to the cyto- 
lytic assay of RE2 on MS-S2 cells at the indicated  time,  and  cytotoxic 
activity was evaluated at the time when cytochalasin was added (O) and 
at  the end  of the assay (60 rain)  (0). 
MS-S2  cells  with  anti-K k and  anti-D k mAbs.  It  was  also 
found that the RE2 determinant is expressed on a T cell leu- 
kemic line RMA selected from the C57BL/6-derived RBL- 
5 lymphoma, but not on an MHC class I defective mutant, 
that  is,  RMA-S cells derived from RMA (Fig.  7 c).  These 
results indicate that the RE2 determinant is strongly related 
to  class  I  molecules• 
Immunoprecipitation  from T Cell Clone MS-S2, Spleen Cells, 
and T Cell Clone 24-2.  The lysate of surface-labeled MS-S2 
cells and spleen cells with or without in vitro activation were 
analyzed  by  SDS-PAGE  after  immunoprecipitation  with 
normal rat serum and RE2, RE1, and $27 mAbs. RE2 and 
$27 precipitated 44-, 60-, and 90-kD molecules from the T 
cell clone MS-S2 (Fig.  8 a). RE2 precipitated 44-kD and 60- 
kD molecules from freshly isolated  spleen cells (Fig.  8  b), 
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Figure  5.  Blocking of cytotoxicity of RE2 by cytochalasins. Cytotoxic 
activity of RE2 on MS-S2 cells was measured in the presence of various 
reagents  under  conditions  described in Materials  and Methods. 
Figure  7.  Expression of the RE2 determinant  on thymocytes,  spleen 
cells, and cell lines. (a) Thymocytes  and spleen cells derived from a C3H 
mouse, as well as (c) T cell leukemic line RMA cells and MHC class I-defec- 
tive mutant  RMA-S cells were  stained with RE2 mAb as described in 
Materials and Methods.  Staining  profiles with RE2 are shown  by solid 
lines. Negative controls  are shown by dotted lines. (b) MS-S2 cells were 
incubated with RE2 mAb followed by the staining with anti-K  ~ or anti- 
DK Staining profiles of anti-class  I mAb without or with RE2 incuba- 
tion are shown by dotted lines and those with RE2 incubation  are shown 
by solid lines. 
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clone MS-S2, spleen cells, and T cell  clone  24-2. 
(a) T cell clone MS-S2 cells, (b) freshly isolated 
spleen cells, (c) Con A-activated spleen  calls (in- 
cubated with 2/~g/ml of Con A for 24 h), and 
(d) T cell clone 24-2 cells surface  labeled with 
1251 by the iodogen method. NP-40  lysate  of the 
cells was subjected  to immunoprecipitation with 
normal rat serum (lane I), anti-K  k (11-4.1) (lane 
2), RE1 (lane  3), RE2 (lane 4), $27 (hne 5), anti- 
32-microglobulin (lane 6), and anti-K  s (28-8-6s) 
(lane 7) mAbs. 
whereas the antibody precipitated the additional 90-kD mol- 
ecule from Con A-activated spleen cells (Fig. 8 c). RE1 mAb 
also precipitated 44- and 60-kD molecules from freshly iso- 
lated  spleen cells  and  the additional  90-kD  molecule from 
the activated spleen cells.  To further  characterize  RE2  and 
class I  determinants,  immunoprecipitates  with  RE2,  anti- 
32- microglobulin,  and anti-K b mAbs from the lysates of T 
cell clone 24-2 (B6C3F1 origin) cells were analyzed by SDS- 
PAGE. RE2, anti-B2-microglobulin (aUotype b specific), and 
anti-K  ~ mAbs precipitated  both  44-  and  90-kD  molecules 
(Fig.  8 d).  When immunoprecipitates  with RE2 were ana- 
lyzed  by  15%  SDS-PAGE,  14-kD  molecules,  which  have 
similar molecular masses as 32-microglobulin, were detected 
(data  not  shown). 
Discussion 
During the course of our study searching for a xenogenic 
antibody specific for mouse T cell membrane molecules, we 
incidentally found that one mAb, RE2, induced a complement- 
independent cell lysis of a T  cell clone used for screening of 
mAbs.  The  nature  of the  cytotoxicity was  different  from 
necrosis and apoptosis in various aspects:  there were giant 
holes on the  surface of target  cells  induced within  5  min, 
and mitochondrial condensation and deformation instead of 
swelling were observed. There were no apoptotic bodies in 
dead cells, and the structure of the nucleus was preserved after 
the destruction  of the cell membrane. 
There are two reports on mAbs that induce apoptotic death 
of lymphocytes. Anti-Apo-1 and anti-Fas  can induce comple- 
ment-independent cell death in activated or malignant human 
lymphocytes and fibroblasts (22, 37). The cell death induced 
by these mAbs has been defined as apoptosis since a typical 
DNA fragmentation was observed in attacked cells. The cell 
death induced by RE2 is different since no DNA fragmenta- 
tion has been detected in treated cells. This report described 
the characteristic features of the cell death induced by RE2 
compared with  those of necrotic and apoptotic cell death. 
Our results indicated that the cross-linking of cell surface 
molecules  reactive  with  RE2  mAb  induced  complement- 
independent cell lysis. We are unable to determine the mole- 
cule responsible for this cell death caused by RE2. The mAb 
RE2 immunoprecipitated 90-, 60-, and 44-kD molecules from 
activated spleen cells and T  cell clones. However, the same 
60-  and 44-kD  molecules could be precipitated  even from 
resting spleen cells and some T cell lines that were not sensi- 
tive to the cytolytic activity of RE2.  It was noted that  the 
90-kD molecule was detectable only on the cells that  were 
sensitive to  the cytolytic activity of RE2.  However, all  of 
the 44-, 60-, and 90-kD proteins were immunoprecipitated 
by a noncytotoxic rat mAb RE1. Anti-class I or 32-micro- 
globulin mAb (11-4.1 and $19.8) having no cytolytic activity 
also precipitated the same 90-kD molecule from the activated 
T cells. RE2 determinant was not expressed on a class I-defec- 
tive leukemic cell line.  RE2 blocked the staining  of MHC 
class I on T cell clones.  The results indicated that RE2 recog- 
nizes an epitope that is on an MHC class I polymorphic re- 
gion detectable by conventional anti-class I antibodies or a 
molecule closely associated with MHC class I  after activa- 
tion.  The possibility remains that lymphocytes are induced 
to death only when a unique structure in class I heavy chain 
dimers  is recognized  (38),  Since anti-class  I  antibodies,  as 
well as rat mAb RE1 having similar specificities  to RE2, ex- 
hibited no cytolytic activity, the target molecule involved in 
cytolysis may not  simply be the MHC class  I  itself.  Also, 
since the antibody could not kill somatic ceils other than lym- 
phocytes, the target molecules may be uniquely expressed on 
T and B ceils. A hamster mAb ($27) obtained by immunizing 
the RE2 immunoprecipitates  of T  cell lysate expressed the 
same complement-independent  cytolytic activity (data  not 
shown). Again, this hamster antibody was found to precipi- 
tate the same class I molecules from T  cell clones and acti- 
vated lymphoid cells. These results suggested that RE2 mAb 
can recognize a structure on class I molecules that is involved 
in the association with unknown membrane molecules respon- 
sible for the cytotoxicity. Such molecules may be present only 
in T and B cells, and they can associate with class I only after 
activation.  Indeed,  the cytolytic activity of RE2 was com- 
pletely blocked by cytochalasin B or cytochalasin D, which 
have no influence on class  I molecules themselves.  The in- 
volvement of a cytoskeleton-dependent active process was sug- 
gested not only by experiments with cytochalasins. If the target 
cells were attached to the culture dish, they became resistant 
2013  Matsuoka  et al. to the cytotoxic activity of RE2. Actin filaments of cells are 
known to be depolymerized by cytochalasin B and cytochalasin 
D. In the condition where the cells adhere to the plastic wall, 
they are known to assemble each other to form stress fibers 
(39). The fact that cytochalasins immediately stopped the RE2- 
induced killing suggests that a cytoskeleton-dependent pathway 
is essential  for the cytotoxicity. 
The cell death observed with RE2 did not involve the apop- 
totic process with DNA fragmentation. This indicates that 
the site of action of RE2 mAb is different from that of anti- 
Fas and anti-Apo-1. The kinetics of cell death and target cell 
distribution are also different. RE2 could not kill or stain 
the murine Fas antigen-transfected Jurkat cell J6 (data not 
shown). 
We were unable to define the mechanism of this RE2- 
induced cell death. However, it represents  a novel type of 
cell death caused by an antibody apart from complement- 
dependent necrosis and -independent apoptosis.  Since RE2 
mAb kills only activated but not resting T and B cells, such 
a mechanism may be involved in an exclusion of autoreactive 
lymphoid  cells at the developmental and effector limbs of the 
immune response.  The formation of the target complex of 
RE2 on the cell surface of activated lymphoid cells may have 
a physiologic role for the lymphocyte turnover, although the 
triggering may involve other mechanisms. The analysis of 
the sensitivity of dividing lymphoma cells may help us to 
develop  a therapeutic device for leukemic cells. 
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